Literature DB >> 10457298

Respiratory morbidity of hospitalized children with Trisomy 21.

J M Hilton1, D A Fitzgerald, D M Cooper.   

Abstract

OBJECTIVE: To review the respiratory morbidity in children with Trisomy 21 admitted to a teaching hospital.
METHODOLOGY: A retrospective chart review of 232 admissions to John Hunter Children's Hospital during a 6.5-year period (1991-98). The primary outcome measures included: (i) primary reason for admission, (ii) concomitant respiratory pathology, (iii) admission to the Intensive Care Unit (ICU), (iv) length of stay and (v) costs of admission.
RESULTS: Fifty-four per cent of admissions were primarily for respiratory tract pathology, dominated by pneumonia, bronchiolitis and croup. Admission to the ICU was required for 10% of admissions, most commonly for pneumonia (10/23). Congenital heart disease (CHD) was present in 33% of patients. The median length of stay and cost of admission for a child with Trisomy 21 (without CHD) with common respiratory conditions such as bronchiolitis, asthma or pneumonia was two to three times greater than in patients without Trisomy 21.
CONCLUSION: Lower respiratory pathology is most common cause for acute hospital admission in children with Trisomy 21. The presence of CHD did not influence admission rates to hospital. However, patients with CHD had longer lengths of stay, appeared to have more severe illness, were more likely to require admission to an ICU and were more likely to require ventilatory support.

Entities:  

Mesh:

Year:  1999        PMID: 10457298     DOI: 10.1046/j.1440-1754.1999.00386.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  28 in total

1.  Epidemiology of pyridoxine dependent seizures in the Netherlands.

Authors:  J V Been; L A Bok; P Andriessen; W O Renier
Journal:  Arch Dis Child       Date:  2005-09-13       Impact factor: 3.791

2.  Hospitalisations from birth to 5 years in a population cohort of Western Australian children with intellectual disability.

Authors:  K Williams; H Leonard; E Tursan d'Espaignet; L Colvin; L Slack-Smith; F Stanley
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

3.  Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome.

Authors:  Ayse Nazli Seckin; Hulya Ozdemir; Ayca Ceylan; Hasibe Artac
Journal:  Clin Exp Med       Date:  2017-02-14       Impact factor: 3.984

4.  Case 2: Recurrent lower respiratory tract infections in a child with Down syndrome.

Authors:  Bashar Al-Khaledi; Melanie Lewis; Joanna E Maclean
Journal:  Paediatr Child Health       Date:  2014-01       Impact factor: 2.253

Review 5.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

6.  Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?

Authors:  Troy T Rohn; Katie L McCarty; Julia E Love; Elizabeth Head
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-12-08

7.  Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus.

Authors:  Chantal J M Broers; Reinoud J B J Gemke; Michel E Weijerman; Koen F van der Sluijs; A Marceline van Furth
Journal:  J Clin Immunol       Date:  2011-12-15       Impact factor: 8.317

8.  Pediatric emergency room presentation of congenital heart disease.

Authors:  Yun Sik Lee; Jae Suk Baek; Bo Sang Kwon; Gi Beom Kim; Eun Jung Bae; Chung Il Noh; Jung Yun Choi; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-01-27       Impact factor: 3.243

9.  Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark.

Authors:  Jin Liang Zhu; Henrik Hasle; Adolfo Correa; Diana Schendel; J M Friedman; Jørn Olsen; Sonja A Rasmussen
Journal:  Am J Med Genet A       Date:  2013-02-12       Impact factor: 2.802

Review 10.  Diffuse alveolar hemorrhage in children with trisomy 21.

Authors:  Jessica L Bloom; Benjamin Frank; Jason P Weinman; Csaba Galambos; Sean T O'Leary; Deborah R Liptzin; Robert C Fuhlbrigge
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-17       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.